The European Patent Office (EPO) has published patent application EP4630427A1, detailing new solid forms of naphthyridine compounds. The application was filed by Amgen Inc. and lists specific inventors. The publication includes International Patent Classification (IPC) codes related to organic chemistry and pharmaceutical applications, such as anti-cancer agents.

This publication serves as a notice of a patent application and does not impose immediate compliance obligations on regulated entities. Companies involved in pharmaceutical research and development, particularly those working with similar chemical structures, should note this patent filing for potential intellectual property considerations and competitive landscape awareness.